Search results for Apolipoprotein

Anti-Apolipoprotein A I antibody, Abcam, AB227455

Anti-Apolipoprotein A I antibody, Abcam, AB7613

This antibody has been used to determine that atherosclerotic lesions in the human aorta contain considerable amounts of lipoproteins. These lipoproteins were observed to be complexed with components of the extracellular matrix (especially LDL and proteoglycans). The role of these matrix-lipoprotein complexes is not entirely clear, however, animal models of atherosclerosis have shown that increased cellular proliferation and increased production of extracellular matrix components occur following injury to the intimal layer of the aorta.

Anti-Apolipoprotein A I antibody, Abcam, AB7614

This antibody has been used to determine that atherosclerotic lesions in the human aorta contain considerable amounts of lipoproteins. These lipoproteins were observed to be complexed with components of the extracellular matrix (especially LDL and proteoglycans). The role of these matrix-lipoprotein complexes is not entirely clear, however, animal models of atherosclerosis have shown that increased cellular proliferation and increased production of extracellular matrix components occur following injury to the intimal layer of the aorta.

Anti-Apolipoprotein B antibody, Abcam, AB20737

What is this antibody validated in? Anti-Apolipoprotein B antibody (ab20737) is a rabbit polyclonal antibody and is validated for use in Western Blot (WB) in Human, Mouse samples. What is the molecular weight of Apolipoprotein B? Anti-Apolipoprotein B (ab20737) specifically detects a band for Apolipoprotein B (UniProt: P04114) at a molecular weight of 515kDa. Trusted by the scientific community Anti-Apolipoprotein B (ab20737) was first used in a scientific publication in 2005 and has been cited over 80 times in peer-reviewed journals. Reviewed by scientists Anti-Apolipoprotein B (ab20737) has over 5 independent reviews from customers.

Anti-Apolipoprotein B antibody, Abcam, AB231574

Anti-Apolipoprotein B antibody, Abcam, AB31992

Anti-Apolipoprotein B antibody, Abcam, AB7616

This antibody has been used to determine that atherosclerotic lesions in the human aorta contain considerable amounts of lipoproteins. These lipoproteins were observed to be complexed with components of the extracellular matrix (especially LDL and proteoglycans). The role of these matrix-lipoprotein complexes is not entirely clear, however, animal models of atherosclerosis have shown that increased cellular proliferation and increased production of extracellular matrix components occur following injury to the intimal layer of the aorta. At least 9 distinct polymorphic forms of apolipoproteins are known. The apolipoproteins act as stabilizers of the intact lipoprotein particles. Quantitative measurements of HDL, LDL and VLDL particles in human serum are often used to estimate an individuals' relative risk of coronary heart disease. In addition, quantitative immunological measurements of certain apolipoproteins (especially A-1 and B) have been suggested to be more accurate estimators of coronary heart disease than measurements of lipoprotein particles (especially HDL and LDL). Abcam's apo-lipoproteins are derived from human plasma by density gradient ultracentrifugation and HPLC.

Anti-Apolipoprotein CIII antibody, Abcam, AB21032

What is this antibody validated in? Anti-Apolipoprotein CIII antibody (ab21032) is a rabbit polyclonal antibody and is validated for use in Western Blot (WB), Immunocytochemistry/immunofluorescence (ICC/IF), ELISA in Human, Monkey samples. What is the molecular weight of Apolipoprotein CIII? Anti-Apolipoprotein CIII (ab21032) specifically detects a band for Apolipoprotein CIII (UniProt: P02656) at a molecular weight of 11kDa.

Anti-Apolipoprotein CIV antibody, Abcam, AB232710

Anti-Apolipoprotein E antibody, Abcam, AB24139